Literature DB >> 7319859

Complications of definitive radiotherapy for carcinoma of the prostate.

M V Pilepich, C A Perez, B J Walz, F R Zivnuska.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 7319859     DOI： 10.1016/0360-3016(81)90029-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  6 in total

Review 1.  Complications of radiation therapy and factors in their prevention.

Authors:  J D Cox; R W Byhardt; J F Wilson; J S Haas; R Komaki; L E Olson
Journal:  World J Surg       Date:  1986-04       Impact factor: 3.352

2.  Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30.

Authors:  G Borghede; M Sullivan
Journal:  Qual Life Res       Date:  1996-04       Impact factor: 4.147

3.  High-dose-rate brachytherapy combined with long-term hormonal therapy for high-risk prostate cancer: results of a retrospective analysis.

Authors:  Ryoong-Jin Oh; Yasuo Yoshioka; Eiichi Tanaka; Hiroya Shiomi; Iori Sumida; Fumiaki Isohashi; Osamu Suzuki; Koji Konishi; Yoshifumi Kawaguchi; Satoaki Nakamura; Masahiro Kato; Takehiro Inoue
Journal:  Radiat Med       Date:  2006-01

4.  Docetaxel and bortezomib downregulate Bcl-2 and sensitize PC-3-Bcl-2 expressing prostate cancer cells to irradiation.

Authors:  Wengang Cao; Kathleen T Shiverick; Kazunori Namiki; Yoshihisa Sakai; Stacy Porvasnik; Cydney Urbanek; Charles J Rosser
Journal:  World J Urol       Date:  2008-07-02       Impact factor: 4.226

5.  Prostate cancer: results of external irradiation.

Authors:  E K Reddy; L Krishnan; S Giri; R G Evans; W K Mebust; J W Weigel
Journal:  J Natl Med Assoc       Date:  1993-02       Impact factor: 1.798

6.  Urinary function and quality of life after radiotherapy for prostate cancer in patients with prior history of surgical treatment for benign prostatic hyperplasia.

Authors:  Mélanie Guilhen; Christophe Hennequin; Idir Ouzaid; Ingrid Fumagalli; Valentine Martin; Sophie Guillerm; Pierre Mongiat-Artus; Vincent Ravery; François Desgrandchamps; Laurent Quéro
Journal:  Radiat Oncol       Date:  2018-10-24       Impact factor: 3.481
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.